Search

Your search keyword '"Drug Evaluation, Preclinical"' showing total 1,328 results

Search Constraints

Start Over You searched for: Descriptor "Drug Evaluation, Preclinical" Remove constraint Descriptor: "Drug Evaluation, Preclinical" Publisher izdatelstvo meditsina Remove constraint Publisher: izdatelstvo meditsina
1,328 results on '"Drug Evaluation, Preclinical"'

Search Results

1. [Embryotoxic properties of the Russian anthelmintic nadinate].

3. [Evaluation of the antihymenolepic activity of a number of chlorinated and brominated salicylanilide derivatives].

4. [Investigation of multyphytoadaptogene anti-radiation efficacy in dogs experiments].

5. [Preclinical investigation of pharmaceuticals impact against cytochrome P450 activity and prognosis of substrate affinity as means for providing substrate therapy safety].

6. [Microbial test-system for screening of inhibitors of sterol biosynthesis].

7. [In vitro cytotoxicity of nitroxyl radicals with respect to tumor and diploid human cells and estimation of their antiviral activity].

8. [Therapeutic efficacy of Triazavirin, a novel Russian chemotherapeutic, against influenza virus A (H5N1)].

9. [Efficacy of enterocin S760 in treatment of mice with anthrax infection due to Bacillus anthracis M-71].

10. [The compound MCT-21 and its antihymenolepidose activity].

11. [Antihymenolepidose activity of the compound MCT-22: preparation and study].

12. [Mosquito fevers. Classification of viruses, epidemiology, prevention].

13. [Preparation of MCT-13 and investigation of its activity against hymenolepidosis].

14. [Antihymenolepidose activity of the compound MST-02].

15. [Preclinical trials of L-lysine-alpha-oxidase, an antitumor enzyme].

16. [Evaluation of antihymenolepidose activity of the compound MCT-03].

17. [Evaluation of antihymenolepidose activity of the compound MST-04].

18. [Levofloxacin (Tavanic) in complex therapy of tuberculosis].

19. [Evaluation of the antihymenolepidic activity of the drug MST-05].

20. [Influence of membrane-active polyanions on various stages of the human cytomegalovirus life cycle in vitro].

21. [Stellanin-PEG 3% ointment: comparative antimicrobial activity against surgical infection pathogens].

22. [Hixozide, a novel combined antituberculosis preparation].

23. [Evaluation of the antihymenolepidous activity of cyclarin].

24. [Evaluation of the trichellocidal activity of lantirin (IMP-17)].

25. [Evaluation of the anticestodal activity of marnatol].

26. [Acute toxicity and antihymenolepiac activity of the new drug feliram].

27. [The new effective anticestodian agent fluxane].

28. [Estimation of the spectrum of antihelminthic activity of VIVALIN (VIG-08)].

30. [Problems of screening novel antituberculosis antibiotics. 3. New data on mechanism of action of antituberculosis agents].

31. [Design of a Russian sample of the antifascioliasis antihelminthic triclabendazole and evaluation of its therapeutic efficiency].

32. [The new agent IMP-1524: design, acute toxicity, and antihymenolepidous activity].

33. [Experimental rationale for the optimization of chemotherapy for alveococciasis].

34. [Preclinical investigation and standardization of metronidazole soft dosage forms].

35. [Efficacy of the Russian anthelmintic agent trichlorophen].

36. [Immunomodulating, antioxidant and hepatoprotective effects of immobilized dosage forms of rifampicin and cephalexin].

37. [Activity of the anthelmintic agent trichlorophen on the models of human helminthiasis].

38. [Screening of natural compounds with hypolipidemic activity].

39. [Nikavir (phosphazide)--an antiretroviral agent: anti-HIV activity, toxicology, pharmacokinetics and some perspectives of its clinical use].

40. [Lovastatin effect on ergosterol production and growth of Tolypocladium inflatum 106].

41. [Experimental rationale for the use of medapec as the drug of choice in treating echinococcosis].

42. [Experimental basis for the use of new dosage forms of doxorubicin for correction of its hepatotoxic, prooxidant and immunosuppressory effects].

43. [Estimation of the efficacy of screened natural hypolipidemic compounds in a model of rabbit hypercholesterolemia].

44. [Screening of natural immunosuppressors by their ability to modify steroid synthesis in hepatocytes].

46. [Synthesis and antibacterial activity of the new 9-aminoacridine, 10,11-dihydro-5H-dibenzo[b,f]azepine, polyfluoro 5,6-dihydro-1,3,5-oxadiazine derivatives].

47. [Innovative approaches to the development of novel antibacterial agents].

48. [The functional-morphological characteristics of alcohol-induced pathology as dependent on the nature of the intoxication and its nootropil correction in an experiment].

49. [An improvement in a new method for the surgical treatment of echinococcosis].

50. [The synthesis and study of the trichinellacidal activity of bromine and chlorine derivatives of 8-quinolyloxysalicylanilides].

Catalog

Books, media, physical & digital resources